BlackRock Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

BlackRock wird ein jährliches Gewinn- und Umsatzwachstum von 6.2% bzw. 7.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 16.9% betragen.

Wichtige Informationen

6.3%

Wachstumsrate der Gewinne

6.2%

EPS-Wachstumsrate

Capital Markets Gewinnwachstum	8.0%
Wachstumsrate der Einnahmen	7.5%
Zukünftige Eigenkapitalrendite	16.9%
Analystenabdeckung	Good
Zuletzt aktualisiert	13 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Gewinn- und Umsatzwachstumsprognosen

DB:BLQA - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	23,885	7,200	7,645	8,879	6
12/31/2025	22,447	6,899	7,622	8,546	12
12/31/2024	20,180	6,277	7,352	7,987	12
3/31/2024	18,344	5,918	3,824	4,151	N/A
12/31/2023	17,859	5,502	3,821	4,165	N/A
9/30/2023	17,565	5,386	3,786	4,140	N/A
6/30/2023	17,354	5,188	3,912	4,324	N/A
3/31/2023	17,417	4,899	4,517	4,984	N/A
12/31/2022	17,873	5,178	4,423	4,956	N/A
9/30/2022	18,642	5,562	4,375	4,900	N/A
6/30/2022	19,381	5,837	4,488	4,914	N/A
3/31/2022	19,675	6,138	4,655	5,095	N/A
12/31/2021	19,374	5,901	4,603	4,944	N/A
9/30/2021	18,746	5,806	4,737	5,006	N/A
6/30/2021	18,065	5,489	3,955	4,227	N/A
3/31/2021	16,893	5,325	3,918	4,108	N/A
12/31/2020	16,205	4,932	3,549	3,743	N/A
9/30/2020	15,704	4,685	2,786	3,020	N/A
6/30/2020	15,027	4,440	2,707	2,956	N/A
3/31/2020	14,903	4,229	1,923	2,171	N/A
12/31/2019	14,539	4,476	2,630	2,884	N/A
9/30/2019	13,996	4,102	1,895	2,151	N/A
6/30/2019	13,880	4,199	2,239	2,485	N/A
3/31/2019	13,961	4,269	2,762	2,991	N/A
12/31/2018	14,198	4,305	2,871	3,075	N/A
9/30/2018	14,528	5,673	3,799	3,962	N/A
6/30/2018	14,460	5,401	3,894	4,057	N/A
3/31/2018	14,091	5,182	3,804	3,973	N/A
12/31/2017	13,600	4,952	N/A	3,950	N/A
9/30/2017	12,726	3,508	N/A	3,732	N/A
6/30/2017	12,055	3,439	N/A	3,432	N/A
3/31/2017	11,623	3,374	N/A	2,555	N/A
12/31/2016	12,261	3,168	N/A	2,273	N/A
9/30/2016	11,128	3,182	N/A	2,119	N/A
6/30/2016	11,201	3,150	N/A	2,410	N/A
3/31/2016	11,302	3,180	N/A	2,948	N/A
12/31/2015	11,401	3,345	N/A	3,004	N/A
9/30/2015	11,322	3,297	N/A	3,118	N/A
6/30/2015	11,261	3,371	N/A	3,051	N/A
3/31/2015	11,134	3,360	N/A	2,784	N/A
12/31/2014	11,081	3,294	N/A	3,087	N/A
9/30/2014	11,074	3,322	N/A	2,982	N/A
6/30/2014	10,697	3,135	N/A	2,844	N/A
3/31/2014	10,401	3,056	N/A	3,246	N/A
12/31/2013	10,180	2,932	N/A	3,642	N/A
9/30/2013	9,942	2,780	N/A	2,830	N/A
6/30/2013	9,790	2,690	N/A	2,705	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BLQADas prognostizierte Gewinnwachstum (6.2% pro Jahr) liegt über der Sparquote (0.7%).

Ertrag vs. Markt: BLQADie Erträge des Unternehmens (6.2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (18.6% pro Jahr).

Hohe Wachstumserträge: BLQADie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: BLQADie Einnahmen des Unternehmens (7.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (5.1% pro Jahr).

Hohe Wachstumseinnahmen: BLQADie Einnahmen des Unternehmens (7.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BLQADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.9%).

BlackRock Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Ono Pharmaceutical Co., Ltd. (TSE:4528) completed the acquisition of Deciphera Pharmaceuticals, Inc. (NasdaqGS:DCPH) from BlackRock, Inc. (NYSE:BLK), Deerfield Capital, L.P., Redmile Group, LLC Brightstar Associates, LLC and others.

Noble Corporation plc (NYSE:NE) entered into a definitive merger agreement to acquire Diamond Offshore Drilling, Inc. (NYSE:DO) from BlackRock, Inc. (NYSE:BLK), KGH Ltd., The Vanguard Group, Inc., Capital Research Global Investors and others for approximately $1.6 billion.

BlackRock Appoints Yik Ley Chan to Lead the Firm's Private Credit Efforts in Southeast Asia

Upcoming dividend of US$5.10 per share

Johnson & Johnson (NYSE:JNJ) completed the acquisition of Shockwave Medical, Inc. (NasdaqGS:SWAV) from a group of sellers.

Aventis Inc. completed the acquisition of Inhibrx, Inc. (NasdaqGM:INBX) from a group of shareholders.

Chairman & CEO recently sold €23m worth of stock

Now 20% undervalued after recent price drop

First quarter dividend of US$5.10 announced

Metropolis Technologies, Inc. completed the acquisition of SP Plus Corporation (NasdaqGS:SP) from BlackRock, Inc. (NYSE:BLK), River Road Asset Management, LLC, Segall Bryant & Hamill, LLC and others.

BlackRock, Inc. Declares Quarterly Dividend on Common Stock, Payable on June 24, 2024

First quarter 2024 earnings released: EPS: US$10.58 (vs US$7.72 in 1Q 2023)

New York City Employees’ Retirement System Files an Exempt Solicitation Statement to BlackRock

BlackRock (NYSE: BLK) completed the acquisition of the remaining equity interest in SpiderRock Advisors, LLC.

Bluebell Capital Sends Letter BlackRock

BlackRock, Inc. Activates Retirement Solution Offering A Paycheck for Life

SH Residential Holdings, LLC completed the acquisition of M.D.C. Holdings, Inc. (NYSE:MDC) from a group of shareholders.

Future Pak, Ltd. submits a proposal to acquire Vanda Pharmaceuticals Inc. (NasdaqGM:VNDA) from The Vanguard Group, Inc., State Street Corporation (NYSE:STT), BlackRock, Inc. (NYSE:BLK), Dimensional Fund Advisors LP and others for approximately $450 million.

First quarter 2024 earnings released: EPS: US$10.58 (vs US$7.72 in 1Q 2023)

BlackRock, Inc. Announces Not Stand for Re-Election of Bader M. Alsaad as Independent Director

BlackRock, Inc. to Report Q1, 2024 Results on Apr 12, 2024

BlackRock, Inc., Annual General Meeting, May 15, 2024

BlackRock Launches BlackRock USD Institutional Digital Liquidity Fund

Insight Venture Management, LLC and Clearlake Capital Group, L.P. completed the acquisition of Alteryx, Inc. (NYSE:AYX) from a group of shareholders.

Bristol-Myers Squibb Company (NYSE:BMY) completed the acquisition of Karuna Therapeutics, Inc. (NasdaqGM:KRTX) from Capital International Investors, FMR LLC, The Vanguard Group, Inc., T. Rowe Price Group, Inc. (NasdaqGS:TROW) and others.

BlackRock, Inc. (NYSE:BLK) fund managed by sponsor acquired A portfolio of 38 solar energy and battery storage projects from Excelsior Energy Capital LP.

BlackRock, Inc. (NYSE:BLK) fund managed by sponsor acquired A portfolio of 38 solar energy and battery storage projects from Excelsior Energy Capital LP.

Standard General L.P. submits a non-binding proposal letter to acquire remaining 76.78809% stake in Bally's Corporation (NYSE:BALY) from BlackRock, Inc. (NYSE:BLK) and others for approximately $550 million.

BlackRock (NYSE: BLK) agreed to acquire the remaining equity interest in SpiderRock Advisors, LLC.

Morgan Stanley Infrastructure Inc. and BlackRock, Inc. (NYSE:BLK) entered into a purchase and sale agreement to acquire Portland Natural Gas Transmission System, LP from TC PipeLines, LP and Northern New England Investment Company, Inc. for approximately $1.5 billion.

Chairman & CEO recently sold €23m worth of stock

Healthpeak Properties, Inc. (NYSE:PEAK) completed the acquisition of Physicians Realty Trust (NYSE:DOC) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., State Street Corporation (NYSE:STT) and others.

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken